Patents by Inventor Gordon A Jamieson, JR.

Gordon A Jamieson, JR. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Translational dysfunction based therapeutics
    Patent number: 10472677
    Abstract: Provided are methods and compositions for inhibiting eukaryotic translation initiation factor eIF4E. Such methods and compositions may be used alone or in conjunction with other therapies, such as gene therapies, for inhibiting cell proliferation and/or treating cancer.
    Type: Grant
    Filed: July 10, 2013
    Date of Patent: November 12, 2019
    Assignee: Translational Therapeutics, Inc.
    Inventors: Gordon A. Jamieson, Jr., Katherine L. B. Borden, Biljana Culjkovic, Alex Kentsis
  • Mass spectrometry assay for and regulon activity
    Patent number: 9110074
    Abstract: Provided is a highly sensitive high throughput mass spectrometry-based quantitative assay for 4E/4E regulon pathway proteins has been developed which provides for single sample multiplexed analysis, as well as the analysis of protein phosphorylation states. It may be adapted for use as the first single sample analytical method of the 4E/4E regulon biological pathway.
    Type: Grant
    Filed: May 6, 2011
    Date of Patent: August 18, 2015
    Assignee: Translational Therapeutics, Inc.
    Inventor: Gordon A. Jamieson Jr.
  • TRANSLATIONAL DYSFUNCTION BASED THERAPEUTICS
    Publication number: 20140199692
    Abstract: Provided are methods and compositions for inhibiting eukaryotic translation initiation factor eIF4E. Such methods and compositions may be used alone or in conjunction with other therapies, such as gene therapies, for inhibiting cell proliferation and/or treating cancer.
    Type: Application
    Filed: July 10, 2013
    Publication date: July 17, 2014
    Applicant: Translational Therapeutics, Inc.
    Inventors: Gordon A. Jamieson, JR., Katherine L. B. Borden, Biljana Culjkovic, Alex Kentsis
  • Mass spectrometry assay for eIF4E and eIF4E regulon activity
    Patent number: 8604692
    Abstract: Provided is a highly sensitive high throughput mass spectrometry-based quantitative assay for 4E/4E regulon pathway proteins has been developed which provides for single sample multiplexed analysis, as well as the analysis of protein phosphorylation states. It may be adapted for use as the first single sample analytical method of the 4E/4E regulon biological pathway.
    Type: Grant
    Filed: May 6, 2010
    Date of Patent: December 10, 2013
    Assignee: Translational Therapeutics, Inc.
    Inventor: Gordon A. Jamieson, Jr.
  • Translational dysfunction based therapeutics
    Patent number: 8497292
    Abstract: Provided are methods and compositions for inhibiting eukaryotic translation initiation factor. Such methods and compositions may be used alone or in conjunction with other therapies, such as gene therapies, for inhibiting cell proliferation and/or treating cancer.
    Type: Grant
    Filed: June 27, 2008
    Date of Patent: July 30, 2013
    Assignee: Translational Therapeutics, Inc.
    Inventors: Gordon A. Jamieson, Jr., Katherine L. B. Borden, Biljana Culjkovic, Alex Kentsis
  • MASS SPECTROMETRY ASSAY FOR eIF4E AND eIF4E REGULON ACTIVITY
    Publication number: 20110319295
    Abstract: Provided is a highly sensitive high throughput mass spectrometry-based quantitative assay for 4E/4E regulon pathway proteins has been developed which provides for single sample multiplexed analysis, as well as the analysis of protein phosphorylation states. It may be adapted for use as the first single sample analytical method of the 4E/4E regulon biological pathway.
    Type: Application
    Filed: May 6, 2011
    Publication date: December 29, 2011
    Inventor: Gordon A. Jamieson, JR.
  • MASS SPECTROMETRY ASSAY FOR eIF4E AND eIF4E REGULON ACTIVITY
    Publication number: 20100317043
    Abstract: Provided is a highly sensitive high throughput mass spectrometry-based quantitative assay for 4E/4E regulon pathway proteins has been developed which provides for single sample multiplexed analysis, as well as the analysis of protein phosphorylation states. It may be adapted for use as the first single sample analytical method of the 4E/4E regulon biological pathway.
    Type: Application
    Filed: May 6, 2010
    Publication date: December 16, 2010
    Inventor: Gordon A. Jamieson, JR.
  • Translational Dysfunction Based Therapeutics
    Publication number: 20090163564
    Abstract: Provided are methods and compositions for inhibiting eukaryotic translation initiation factor eIF4E. Such methods and compositions may be used alone or in conjunction with other therapies, such as gene therapies, for inhibiting cell proliferation and/or treating cancer.
    Type: Application
    Filed: June 27, 2008
    Publication date: June 25, 2009
    Applicant: Translational Therapeutics, Inc.
    Inventors: Katherine L.B. Borden, Biljana Culjkovic, Gordon A Jamieson, JR., Alex Kentsis